C

Centrum Medyczne Medyk | Centrum Medyczne Medyk Rejtana

Research site

(Unclaimed)

Location

Aleja Rejtana 53, Rzeszów, Subcarpathia, Poland

Site insights

Top conditions

Top treatments

ARO-APOC3

AMT-101

Risankizumab

ATB200

Ocrelizumab

OSE-127

Adalimumab

ST-0529

AT2221

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 13 total trials

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (O'HAND)

This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple s...

Active, not recruiting

Multiple Sclerosis, Primary Progressive

Drug: Ocrelizumab

Drug: Placebo

Study of ARO-APOC3 in Adults With Dyslipidemia

This is an open-label extension of the parent studies AROAPOC3-2001 and AROAPOC3-2002. Adult participants with dyslipidemia who completed the blinded...

Active, not recruiting

Dyslipidemias

Drug: ARO-APOC3

Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

Randomized, Placebo-controlled, Double-blind, Parallel-group, Multicenter, Phase 2a Study of the Efficacy and Safety of Oral AMT-101 in Subjects with...

Active, not recruiting

Ulcerative Colitis

Other: Placebo (oral)

Drug: AMT-101 (oral)

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Transmural healing (TMH) is recognized as a potentially important measure of Crohn's disease (CD) activity but not a formal target. Observational stu...

Enrolling

Disease Crohn

Crohn Disease

Biological: Vedolizumab